-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Events
Latest From Events
BioGENEius Award Alumni Update: Jennifer Chen
By Jennifer Chen, Participant, 2011 U.S. National BioGENEius Challenge I am very fortunate to have participated in the U.S. National BioGENEius Challenge. In addition to presenting my research to professionals involved in all aspects of biotechnology, I had the incredible opportunity of understanding the work of my peers, who are similarly enthusiastic about the diverse ways in which science can affect society. Furthermore, the BioGENEius program generously gave me the opportunity to attend the BIO Read More >
2012 BIO International Convention: Q&A with Progenika
In anticipation of the 2012 BIO International Convention we spoke with Progenika, a newly established Spanish healthcare company, to get their perspective on the event. Progenika develops, produces, and commercializes tools for the diagnosis and prognosis of diseases and for predicting response to drug treatment. Read on to learn more about this innovative company. 1) Progenika is a newly established company that has created new subsidiaries; it has internationalized and brought products to the market Read More >
International Programming Highlights
For those looking to take advantage of all the Convention has to offer, specifically within the international programming, you have landed in the right spot. Take a few minutes to review our international programming highlights. For more information, visit myBIO and map your day out! International Programming Highlights –MONDAY Global Biotechnology Forum: The BRICs and Beyond 10:00 – 11:30 a.m., Room 259 B The Global Biotechnology Forum: The BRICs and Beyond will explore how governments Read More >
2012 BIO International Convention: Exploring Massachusetts
By Bob Coughlin, President & CEO, MassBio Of course the 2012 BIO International Convention will be a great chance to connect, partner, network and learn. And convention-goers will have the chance to check out Boston’s Innovation District, which surrounds the Convention Center. But why not take some time while you’re in the Boston area to explore the biotech clusters outside metro Boston? There’s something for everyone here in Massachusetts! Head North of the City… The Read More >
Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention
In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation. Read More >
